- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Oct 20, 2023
Highlights
- Market Cap
- $6.84B
- Enterprise Value
- $6.29B
- EPS (TTM)
- -€6.89
- Total Revenue (TTM)
- €10.79M
- Gross Profit (TTM)
- €9.76M
- EBITDA (TTM)
- -€411.59M
- Year Range
- $6.89 - $148.83
- Target Price
- $145.67
- ROA (TTM)
- -78.46%
- ROE (TTM)
- -100.71%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ABVX Performance Chart
Abivax SA American Depositary Shares (ABVX) is down 27.0% since the beginning of the year. At $98 per share, ABVX is trading 33.9% below its 52-week high of $149.
Loading charts...
Returns By Period
Abivax SA American Depositary Shares (ABVX) has returned -27.01% so far this year and 1,510.97% over the past 12 months.
Abivax SA American Depositary Shares
- 1D
- -3.18%
- 1M
- -19.31%
- YTD
- -27.01%
- 6M
- -28.85%
- 1Y
- 1,510.97%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
ABVX Monthly Returns History
Based on dividend-adjusted daily data since Oct 20, 2023, ABVX's average daily return is +1.00%, while the average monthly return is +26.19%. At this rate, an investment would double in approximately 0.2 years.
Historically, 58% of months were positive and 42% were negative. The best month was Jul 2025 with a return of +838.2%, while the worst month was Jun 2026 at -25.8%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ABVX closed higher 49% of trading days. The best single day was Jul 23, 2025 with a return of +586.0%, while the worst single day was Jun 2, 2026 at -44.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.58% | 9.11% | -8.19% | 5.42% | 12.99% | -25.79% | -27.01% | ||||||
| 2025 | -18.44% | 28.64% | -18.62% | 13.92% | -15.45% | 27.08% | 838.17% | 12.90% | 4.78% | 20.64% | 21.88% | 8.03% | 1,742.28% |
| 2024 | 23.18% | 3.19% | 5.15% | 4.90% | -6.67% | -5.57% | -10.67% | 7.62% | -9.36% | -10.42% | -17.34% | -14.19% | -31.59% |
| 2023 | -20.69% | 10.33% | 5.42% | -7.76% |
Benchmark Metrics
Abivax SA American Depositary Shares has an annualized alpha of 763.05%, beta of 1.67, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 20, 2023.
- This stock captured 572.79% of S&P 500 Index gains and 162.75% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 763.05%
- Beta
- 1.67
- R²
- 0.00
- Upside Capture
- 572.79%
- Downside Capture
- 162.75%
Return for Risk
Risk / Return Rank
ABVX ranks 98 for risk / return — in the top 98% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Abivax SA American Depositary Shares (ABVX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABVX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.81 | ||
| Sortino ratioReturn per unit of downside risk | +10.62 | ||
| Omega ratioGain probability vs. loss probability | 3.29 | 1.32 | +1.97 |
| Calmar ratioReturn relative to maximum drawdown | 30.51 | 2.46 | +28.06 |
| Martin ratioReturn relative to average drawdown | 102.33 | 10.92 | +91.41 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Abivax SA American Depositary Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abivax SA American Depositary Shares was 67.46%, occurring on Apr 8, 2025. Recovery took 72 trading sessions.
The current Abivax SA American Depositary Shares drawdown is 32.26%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -67.46%Apr 2025 | 11mo 18d | 3mo 16d | 1y 2moApr 2024 - Jul 2025 |
2026 bear market2026 | -50.11%Jun 2026 | 5mo 8d | — | 6mo 13hDec 2025 - now |
2023 bear market2023 | -30.17%Oct 2023 | 3d | 3mo 1d | 3mo 4dOct 2023 - Jan 2024 |
2025 correction2025 | -16.73%Dec 2025 | 5d | 5d | 10dDec 2025 - Dec 2025 |
2025 correction2025 | -13.72%Dec 2025 | 8d | 7d | 15dNov 2025 - Dec 2025 |
Drawdown Indicators
| ABVX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.46% | -56.78% | -10.68% |
Max Drawdown (1Y)Largest decline over 1 year | -50.11% | -9.10% | -41.01% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -32.26% | -3.21% | -29.05% |
Average DrawdownAverage peak-to-trough decline | -24.32% | -10.71% | -13.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.91% | 2.04% | +12.87% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Abivax SA American Depositary Shares over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Abivax SA American Depositary Shares is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABVX relative to other companies in the Biotechnology industry. Currently, ABVX has a P/S ratio of 532.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABVX in comparison with other companies in the Biotechnology industry. Currently, ABVX has a P/B value of 13.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ABVX
Add Abivax SA American Depositary Shares to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ABVX